Evidence map›Paper›PMID 24897023›Full record

ReviewInternational journal of molecular sciences2014

SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.

Barbara Palumbo, Tommaso Buresta, Susanna Nuvoli, Angela Spanu, Orazio Schillaci, Mario Luca Fravolini, Isabella Palumbo

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Texture Analysis on [Molecular imaging and biology · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Insight into the Molecular Imaging of Alzheimer's Disease.International journal of biomedical imaging · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Barbara PalumboSection of Nuclear Medicine and Health Physics, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia 06100, Italy. barbara.palumbo@unipg.it.
Tommaso BurestaSection of Nuclear Medicine and Health Physics, Department of Surgical and Biomedical Sciences, University of Perugia, Perugia 06100, Italy. tommaso.buresta@libero.it.
Susanna NuvoliSection of Nuclear Medicine, Department of Clinical and Experimental Medicine, University of Sassari, Sassari 07100, Italy. susannanuvoli@gmail.com.
Angela SpanuSection of Nuclear Medicine, Department of Clinical and Experimental Medicine, University of Sassari, Sassari 07100, Italy. angela.spanu@email.it.
Orazio SchillaciDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Roma 00133, Italy. orazio.schillaci@uniroma2.it.
Mario Luca FravoliniDepartment of Engineering, University of Perugia, Perugia 06100, Italy. mario.fravolini@unipg.it.
Isabella PalumboSection of Radiotherapy Department of Surgical and Biomedical Sciences, University of Perugia, Perugia 06100, Italy. isabella.palumbo@unipg.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear medicine techniques (single photon emission computerized tomography, SPECT, and positron emission tomography, PET) represent molecular imaging tools, able to provide in vivo biomarkers of different diseases. To investigate brain tumours and metastases many different radiopharmaceuticals imaged by SPECT and PET can be used. In this review the main and most promising radiopharmaceuticals available to detect brain metastases are reported. Furthermore the diagnostic contribution of the combination of SPECT and PET data with radiological findings (magnetic resonance imaging, MRI) is discussed.

Indexed as

AnimalsBiomarkers, TumorBrainBrain NeoplasmsHumansMolecular ImagingPositron-Emission TomographyRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonBiomarkers, TumorRadiopharmaceuticals

Identifiers

PMID24897023
PMCPMC4100127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.